Education
About Us
Working with TipRanks
Follow Us
Pharma Bio Services (PBSV)
OTHER OTC:PBSV
Total Valuation
Pharma Bio Services has a market cap or net worth of $14.04M. The enterprise value is $3.34M.
Market Cap$14.04M
Enterprise Value$3.34M
Share Statistics
Pharma Bio Services has 22,918,093 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,918,093
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharma Bio Services’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is 0.08%.
Return on Equity (ROE)-0.06
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)0.08%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee126.79K
Profits Per Employee-10.37K
Employee Count75
Asset Turnover0.58
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pharma Bio Services is ―. Pharma Bio Services’s PEG ratio is 0.11.
PE Ratio―
PS Ratio1.40
PB Ratio0.97
Price to Fair Value0.97
Price to FCF-18.34
Price to Operating Cash Flow0.06
PEG Ratio0.11
Income Statement
In the last 12 months, Pharma Bio Services had revenue of 9.51M and earned -777.62K in profits. Earnings per share was -0.03.
Revenue9.51M
Gross Profit2.52M
Operating Income-1.29M
Pretax Income-755.45K
Net Income-777.62K
EBITDA-1.11M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was 235.87M and capital expenditures -1.53K, giving a free cash flow of 235.71M billion.
Operating Cash Flow235.87M
Free Cash Flow235.71M
Free Cash Flow per Share10.28
Dividends & Yields
Pharma Bio Services pays an annual dividend of $0.075, resulting in a dividend yield of ―
Dividend Per Share$0.075
Dividend Yield―
Payout Ratio-1250.00%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.13
52-Week Price Change27.08%
50-Day Moving Average0.60
200-Day Moving Average0.53
Relative Strength Index (RSI)48.42
Average Volume (3m)7.95K
Important Dates
Pharma Bio Services upcoming earnings date is Feb 4, 2026, TBA (Confirmed).
Last Earnings DateSep 10, 2025
Next Earnings DateFeb 4, 2026
Ex-Dividend DateFeb 28, 2025
Financial Position
Pharma Bio Services as a current ratio of <0.01, with Debt / Equity ratio of 0.60%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap12.40
Net Debt to EBITDA5.94
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Pharma Bio Services has paid 22.17K in taxes.
Income Tax22.17K
Effective Tax Rate-0.03
Enterprise Valuation
Pharma Bio Services EV to EBITDA ratio is -6.10, with an EV/FCF ratio of -9.29.
EV to Sales0.71
EV to EBITDA-6.10
EV to Free Cash Flow-9.29
EV to Operating Cash Flow-11.91
Balance Sheet
Pharma Bio Services has $10.73B in cash and marketable securities with $71.36M in debt, giving a net cash position of $10.65B billion.
Cash & Marketable Securities$10.73B
Total Debt$71.36M
Net Cash$10.65B
Net Cash Per Share$464.86
Tangible Book Value Per Share$0.60
Margins
Gross margin is 29.26%, with operating margin of -13.54%, and net profit margin of -8.18%.
Gross Margin29.26%
Operating Margin-13.54%
Pretax Margin-7.94%
Net Profit Margin-8.18%
EBITDA Margin-11.64%
EBIT Margin-13.54%
Analyst Forecast
The average price target for Pharma Bio Services is $0.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$0.50
Price Target Upside-18.03% Downside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-14.75%
EPS Growth Forecast89.89%